分析
对医药市场、供应链、技术和法规的深入分析
分析
2026年8月30日•1 分钟阅读
Celltrion Beats Q2 Market Expectations, Analysts Raise Target Prices
Celltrion reported Q2 revenue of 1.3 trillion KRW and operating profit of 430 billion KRW, surpassing consensus estimates, prompting analysts to lift target prices.
分析
2026年8月30日•1 分钟阅读
Sky Labs Announces KOSDAQ IPO, Plans to Offer 2 Million Shares
Sky Labs submitted its securities filing to the Financial Services Commission and began its public offering, targeting 2 million shares at KRW 13,000‑16,000 each.
分析
2026年8月30日•1 分钟阅读
iM Securities: Pharma/Bio Fundamentals Steady, H2 Focus on Obesity Drugs and ADCs
Korea’s pharma/bio sector lagged the H1 market rally but fundamentals remain solid; iM Securities advises H2 investment in policy‑benefit firms, obesity treatments and ADCs, with long‑term focus on earnings‑growth companies.
分析
2026年8月30日•1 分钟阅读
Kolon Life Science seeks partners for TG-C osteoarthritis gene therapy at BIO Asia–Taiwan 2026
Kolon Life Science will attend BIO Asia–Taiwan 2026 in Taipei (July 15‑19) to meet potential partners for TG‑C, its cell‑gene therapy for osteoarthritis, targeting the Greater China market.
分析
2026年8月30日•1 分钟阅读
CHD Pharma launches Hydration ORS and Electrolyte Glucose Candy, expands electrolyte line
CHD Pharma, formerly Cheonhye-dang, introduced Hydration ORS and electrolyte glucose candy, building on its top‑selling saline‑glucose tablets that led pharmacy orders from July 2025‑June 2026.
分析
2026年8月29日•1 分钟阅读
Fierce Pharma launches weekly Oral GLP‑1 Tracker to monitor Wegovy and Foundayo market share
Fierce Pharma introduces a weekly Oral GLP‑1 Tracker using analysts’ notes and IQVIA data to track prescription trends as Novo Nordisk’s Wegovy and Eli Lilly’s Foundayo compete for the oral weight‑loss market.
分析
2026年8月28日•1 分钟阅读
Gwangdong Pharmaceutical appoints Gi-an84 as brand model for Vita500 Ion Kick
Gwangdong Pharmaceutical selects webtoon artist Gi-an84 as the first brand ambassador for its new ion drink Vita500 Ion Kick, launching a promotional campaign.
分析
2026年8月27日•1 分钟阅读
Klick Health Acquires Oxford PharmaGenesis in Third Takeover Within 18 Months
Klick Health completes its third acquisition in 18 months, buying Oxford PharmaGenesis to expand globally and deepen scientific expertise.
分析
2026年8月26日•1 分钟阅读
Kimball Electronics Pursues M&A to Expand Life‑Science CDMO Footprint in Europe and India
Kimball Electronics announced plans to grow its life‑science contract manufacturing capabilities through acquisitions in Europe and India.
1
分析
2026年8月26日•1 分钟阅读
Korea Secures Enrylaze Supply as Alternative to Discontinued Erwinase for ALL & Lymphoma
Following the shutdown of Erwinase’s manufacturer, Korea’s Rare & Essential Medicines Center signed a contract for Enrylaze, restoring treatment continuity for acute lymphoblastic leukemia and lymphoma patients.
分析
2026年8月26日•1 分钟阅读
Tenpoint’s Yuvezzi Campaign Uses Handcrafted Puppets to Highlight Presbyopia
Tenpoint’s new Yuvezzi consumer campaign uses handcrafted puppets to illustrate everyday blurry‑vision hassles faced by people with presbyopia.
分析
2026年8月26日•1 分钟阅读
Roche Leads PatientView Oncology Reputation Ranking, AstraZeneca Moves to Second
Roche tops PatientView’s oncology reputation ranking, with AstraZeneca climbing to second thanks to breast and lung cancer strengths.